Cancer 24 , 171 (2025)
177 Additionally, the combination of aspirin with oseltamivir phosphate (OP) and gemcitabine enhances the therapeutic outcomes by reducing cell viability, migration, and clonogenic potential, while also sensitizing cells to gemcitabine-induced apoptosis, thus overcoming chemoresistance
Ebrahim, N., Shakirova, K
Weeks 4 to 12 (therapeutic phase) use a 2 to 5 percent concentration once daily, targeting active collagen stimulation and repair
Bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl (BPTES), a potent orally available GLS1 inhibitor that spares GLS2, shows promising antitumor effects against human lymphoma B cells in vitro and in a xenograft mouse model 42